NHLBI

NHLBI
Name	National Heart, Lung, and Blood Institute
Native name	NHLBI
Formed	1948
Preceding1	National Heart Institute
Jurisdiction	United States federal government
Headquarters	Bethesda, Maryland
Chief1 name	Monica M. Bertagnolli
Chief1 position	Director, National Institutes of Health
Parent agency	National Institutes of Health

NHLBI The National Heart, Lung, and Blood Institute is a United States medical research institute focused on cardiovascular, pulmonary, and hematologic diseases and sleep disorders. It operates within National Institutes of Health headquarters in Bethesda, Maryland, supporting basic, clinical, and translational science through intramural programs, extramural grants, and public education campaigns. NHLBI partners with federal agencies, academic centers, industry consortia, and patient organizations to advance prevention, diagnosis, and treatment of conditions such as coronary artery disease, chronic obstructive pulmonary disease, and sickle cell disease.

Overview

NHLBI sponsors research spanning molecular biology, epidemiology, clinical trials, and implementation science, collaborating with institutions like Johns Hopkins University, Harvard University, Massachusetts General Hospital, and Mayo Clinic. The institute supports cohort studies, biorepositories, and data-sharing platforms including projects linked to Framingham Heart Study, Cardiovascular Health Study, and Atherosclerosis Risk in Communities Study. NHLBI-funded work contributes to guidelines developed by organizations such as the American Heart Association, American College of Cardiology, American Thoracic Society, and American Society of Hematology.

History

Established after World War II as the National Heart Institute in 1948, the institute expanded its remit following advances in cardiovascular research and the emergence of pulmonary and hematologic priorities in the late 20th century. Landmark programs emerged during the tenure of leaders who interacted with presidents and policymakers during initiatives like the President's Council on Physical Fitness and national campaigns against smoking endorsed by Surgeon General of the United States. NHLBI played key roles in landmark trials such as those that informed the Framingham Heart Study risk equations and randomized studies that shaped use of antihypertensive agents evaluated in trials involving agents from National Institute of Neurological Disorders and Stroke collaborators. Its history intersects with major biomedical milestones at National Cancer Institute and within the Department of Health and Human Services.

Organizational structure

NHLBI is organized into extramural and intramural divisions that interact with centers and offices across NIH. Extramural programs fund investigators at universities such as Stanford University, University of California, San Francisco, University of Pennsylvania, University of Michigan, and Duke University. Intramural research includes laboratories and clinical units situated at the Clinical Center (NIH), where investigators collaborate with clinicians from Walter Reed National Military Medical Center and specialists trained at Cleveland Clinic. Administrative units liaise with the Office of Management and Budget for appropriations and with advisory groups including the National Advisory Heart, Lung, and Blood Council and panels composed of members from Institute of Medicine committees.

Research programs and initiatives

Major NHLBI initiatives include large-scale trials, precision medicine programs, and networks such as the Heart Failure Network, the Sickle Cell Disease Implementation Consortium, and the Trans-Omics for Precision Medicine program. The institute has funded genomic and proteomic research partnered with consortia like the Human Genome Project legacy groups and infrastructure investments connecting to All of Us Research Program. Clinical trial platforms supported by NHLBI have evaluated interventions involving devices from vendors that collaborate with U.S. Food and Drug Administration review processes and pharmaceuticals assessed in multicenter trials across sites including University of California, Los Angeles and Columbia University. NHLBI programs emphasize health disparities research involving communities served by institutions such as Howard University and Meharry Medical College, and pilot projects with the Bill & Melinda Gates Foundation have targeted global cardiovascular and pulmonary health.

Funding and grants

NHLBI awards investigator-initiated grants (R01), program project grants (P01), and training grants (T32), alongside contracts and cooperative agreements (U01) that fund networks at centers like Children's Hospital of Philadelphia and Boston Children's Hospital. Extramural funding mechanisms support career development awards connected to professional societies including Association of American Medical Colleges and American Federation for Medical Research. Annual appropriations from the United States Congress are supplemented by collaborations with foundations and industry partnerships subject to conflict-of-interest rules overseen by Office of Research Integrity. Peer review is conducted through study sections drawing experts from Yale University, University of Chicago, Northwestern University, and other academic centers.

Public health impact and outreach

NHLBI has influenced clinical practice via evidence that contributed to guidelines promulgated by American College of Cardiology and American Heart Association committees, and public campaigns aligned with Centers for Disease Control and Prevention initiatives on smoking cessation and hypertension awareness. Educational resources developed in collaboration with groups such as the American Lung Association and Patient-Centered Outcomes Research Institute support patient engagement around conditions like asthma, venous thromboembolism, and thalassemia. NHLBI-sponsored cohort data underpin risk calculators used by clinicians at institutions including Massachusetts General Hospital and Brigham and Women's Hospital, while partnerships with community organizations and Historically Black Colleges and Universities such as Spelman College aim to reduce disparities in cardiovascular and hematologic outcomes.

Category:United States federal agencies Category:Medical research institutes